Published in Infect Immun on February 11, 2008
Profiling humoral immune responses to P. falciparum infection with protein microarrays. Proteomics (2008) 2.43
Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen. PLoS One (2016) 2.05
Advances and challenges in malaria vaccine development. J Clin Invest (2010) 2.03
Cell-free protein synthesis: applications come of age. Biotechnol Adv (2011) 1.72
Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A (2009) 1.72
Antibody-profiling technologies for studying humoral responses to infectious agents. Expert Rev Vaccines (2010) 1.67
Practical cell-free protein synthesis system using purified wheat embryos. Nat Protoc (2010) 1.47
Meta-analysis of immune epitope data for all Plasmodia: overview and applications for malarial immunobiology and vaccine-related issues. Parasite Immunol (2009) 1.30
Heterologous expression of plasmodial proteins for structural studies and functional annotation. Malar J (2008) 1.22
A library of functional recombinant cell-surface and secreted P. falciparum merozoite proteins. Mol Cell Proteomics (2013) 1.16
Single amino acid substitution in Plasmodium yoelii erythrocyte ligand determines its localization and controls parasite virulence. Proc Natl Acad Sci U S A (2009) 1.13
Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen. Infect Immun (2011) 1.11
New antigens for a multicomponent blood-stage malaria vaccine. Sci Transl Med (2014) 1.11
Plasmodium immunomics. Int J Parasitol (2010) 1.09
N-terminal prodomain of Pfs230 synthesized using a cell-free system is sufficient to induce complement-dependent malaria transmission-blocking activity. Clin Vaccine Immunol (2011) 1.08
Biosynthesis, localization, and macromolecular arrangement of the Plasmodium falciparum translocon of exported proteins (PTEX). J Biol Chem (2012) 1.08
Targeting sialic acid dependent and independent pathways of invasion in Plasmodium falciparum. PLoS One (2012) 1.06
A plant-produced Pfs230 vaccine candidate blocks transmission of Plasmodium falciparum. Clin Vaccine Immunol (2011) 1.01
Autophagy-related Atg8 localizes to the apicoplast of the human malaria parasite Plasmodium falciparum. PLoS One (2012) 1.00
Functional comparison of Plasmodium falciparum transmission-blocking vaccine candidates by the standard membrane-feeding assay. Infect Immun (2013) 0.98
Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum. Sci Rep (2015) 0.97
Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system. Clin Vaccine Immunol (2010) 0.97
Potent malaria transmission-blocking antibody responses elicited by Plasmodium falciparum Pfs25 expressed in Escherichia coli after successful protein refolding. Infect Immun (2014) 0.96
Plasmodium falciparum Protein Microarray Antibody Profiles Correlate With Protection From Symptomatic Malaria in Kenya. J Infect Dis (2015) 0.93
Serologic markers in relation to parasite exposure history help to estimate transmission dynamics of Plasmodium vivax. PLoS One (2011) 0.93
Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu. Infect Immun (2013) 0.92
Recent advances in recombinant protein-based malaria vaccines. Vaccine (2015) 0.91
Plasmodium vivax: comparison of immunogenicity among proteins expressed in the cell-free systems of Escherichia coli and wheat germ by suspension array assays. Malar J (2011) 0.90
The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax. Infect Immun (2013) 0.89
Production of recombinant proteins from protozoan parasites. Trends Parasitol (2010) 0.88
Novel approaches to identify protective malaria vaccine candidates. Front Microbiol (2014) 0.87
A Library of Plasmodium vivax Recombinant Merozoite Proteins Reveals New Vaccine Candidates and Protein-Protein Interactions. PLoS Negl Trop Dis (2015) 0.86
Systems immunology of human malaria. Trends Parasitol (2012) 0.86
Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10. Parasitol Res (2014) 0.86
Measurement of naturally acquired humoral immune responses against the C-terminal region of the Plasmodium vivax MSP1 protein using protein arrays. Parasitol Res (2011) 0.86
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles. Vaccine (2015) 0.85
Identification and characterization of the Plasmodium falciparum RhopH2 ortholog in Plasmodium vivax. Parasitol Res (2012) 0.85
Immunoprofiling of the tryptophan-rich antigen family in Plasmodium vivax. Infect Immun (2015) 0.83
Towards a comprehensive Plasmodium falciparum merozoite cell surface and secreted recombinant protein library. Malar J (2014) 0.83
A small molecule glycosaminoglycan mimetic blocks Plasmodium invasion of the mosquito midgut. PLoS Pathog (2013) 0.82
Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development. PLoS One (2015) 0.82
Enzymatic characterization of the Plasmodium vivax chitinase, a potential malaria transmission-blocking target. Parasitol Int (2009) 0.81
Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine. Syst Synth Biol (2010) 0.81
A member of the CPW-WPC protein family is expressed in and localized to the surface of developing ookinetes. Malar J (2013) 0.81
Cell-Free Protein Synthesis: Pros and Cons of Prokaryotic and Eukaryotic Systems. Chembiochem (2015) 0.81
Serological responses to a soluble recombinant chimeric Plasmodium vivax circumsporozoite protein in VK210 and VK247 population. Malar J (2013) 0.80
RALP1 is a rhoptry neck erythrocyte-binding protein of Plasmodium falciparum merozoites and a potential blood-stage vaccine candidate antigen. Infect Immun (2013) 0.80
Potent Functional Immunogenicity of Plasmodium falciparum Transmission-Blocking Antigen (Pfs25) Delivered with Nanoemulsion and Porous Polymeric Nanoparticles. Pharm Res (2015) 0.80
Naturally-acquired cellular immune response against Plasmodium vivax merozoite surface protein-1 paralog antigen. Malar J (2015) 0.79
Evaluation of approaches to identify the targets of cellular immunity on a proteome-wide scale. PLoS One (2011) 0.79
A densely overlapping gene fragmentation approach improves yeast two-hybrid screens for Plasmodium falciparum proteins. Mol Biochem Parasitol (2011) 0.78
Apoglobin Stability Is the Major Factor Governing both Cell-free and in Vivo Expression of Holomyoglobin. J Biol Chem (2015) 0.77
Phenotypic dissection of a Plasmodium-refractory strain of malaria vector Anopheles stephensi: the reduced susceptibility to P. berghei and P. yoelii. PLoS One (2013) 0.77
Plasmodium Merozoite TRAP Family Protein Is Essential for Vacuole Membrane Disruption and Gamete Egress from Erythrocytes. Cell Host Microbe (2016) 0.77
Expression of functional Plasmodium falciparum enzymes using a wheat germ cell-free system. Eukaryot Cell (2013) 0.77
Maternal-foetal transfer of Plasmodium falciparum and Plasmodium vivax antibodies in a low transmission setting. Sci Rep (2016) 0.76
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes. Infect Immun (2015) 0.76
High-Level Expression, Purification and Characterization of A Recombinant Plasmodium vivax Apical Membrane Antigen 1: Implication for vivax Malaria Vaccine Development. Cell J (2015) 0.75
Cell-Free Expression and In Situ Immobilization of Parasite Proteins from Clonorchis sinensis for Rapid Identification of Antigenic Candidates. PLoS One (2015) 0.75
Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate. Sci Rep (2017) 0.75
Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria. Malar J (2016) 0.75
Evaluation of the Immunogenicity of Diphtheria Toxoid Conjugated to Salmonella Typhimurium-Derived OPS in a Mouse Model: A Potential Vaccine Candidate Against Salmonellosis. Iran Red Crescent Med J (2016) 0.75
In vitro human cell-free expression system for synthesis of malaria proteins. Parasitol Res (2012) 0.75
Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions. PLoS Negl Trop Dis (2017) 0.75
Vaccine candidate discovery for the next generation of malaria vaccines. Immunology (2017) 0.75
Study roadmap for high-throughput development of easy to use and affordable biomarkers as diagnostics for tropical diseases: a focus on malaria and schistosomiasis. Infect Dis Poverty (2017) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Human malaria parasites in continuous culture. Science (1976) 59.70
Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89
Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (1984) 8.18
Malaria in 2002. Nature (2002) 5.19
Specificity of the protective antibody response to apical membrane antigen 1. Infect Immun (2001) 4.51
A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains. Nature (1988) 3.31
The disulfide bond structure of Plasmodium apical membrane antigen-1. J Biol Chem (1996) 3.15
A cell-free protein synthesis system for high-throughput proteomics. Proc Natl Acad Sci U S A (2002) 2.55
Proteolytic processing and primary structure of Plasmodium falciparum apical membrane antigen-1. J Biol Chem (2001) 2.53
Progress and challenges for malaria vaccines. Nature (2002) 2.50
Heterologous expression of proteins from Plasmodium falciparum: results from 1000 genes. Mol Biochem Parasitol (2006) 2.45
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science (1985) 2.44
Genome-scale protein expression and structural biology of Plasmodium falciparum and related Apicomplexan organisms. Mol Biochem Parasitol (2006) 2.39
Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli. Infect Immun (2002) 2.37
Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine (2005) 2.18
The diversity of dolichol-linked precursors to Asn-linked glycans likely results from secondary loss of sets of glycosyltransferases. Proc Natl Acad Sci U S A (2005) 2.14
Protein glycosylation in the malaria parasite. Parasitol Today (1999) 1.90
Saccharomyces cerevisiae recombinant Pfs25 adsorbed to alum elicits antibodies that block transmission of Plasmodium falciparum. Infect Immun (1994) 1.87
Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose. Biotechnology (N Y) (1994) 1.87
The Plasmodium circumsporozoite protein is proteolytically processed during cell invasion. J Exp Med (2005) 1.85
Cell-free protein production and labeling protocol for NMR-based structural proteomics. Nat Methods (2004) 1.78
Development and evaluation of an enzyme-linked immunosorbent assay for Plasmodium vivax-VK247 sporozoites. J Med Entomol (1992) 1.64
Cell-free expression systems for eukaryotic protein production. Curr Opin Biotechnol (2006) 1.58
A bilayer cell-free protein synthesis system for high-throughput screening of gene products. FEBS Lett (2002) 1.56
Expression of malaria transmission-blocking vaccine antigen Pfs25 in Pichia pastoris for use in human clinical trials. Vaccine (2003) 1.43
Apical expression of three RhopH1/Clag proteins as components of the Plasmodium falciparum RhopH complex. Mol Biochem Parasitol (2005) 1.26
Selection of 5'-untranslated sequences that enhance initiation of translation in a cell-free protein synthesis system from wheat embryos. Bioorg Med Chem Lett (2005) 1.10
High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res (2004) 1.07
Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum. Infect Immun (2005) 1.05
Progress towards the development of malaria vaccines. Trends Parasitol (2006) 1.05
Serum antibodies induced by intranasal immunization of mice with Plasmodium vivax Pvs25 co-administered with cholera toxin completely block parasite transmission to mosquitoes. Vaccine (2003) 1.02
Refolding, purification, and crystallization of apical membrane antigen 1 from Plasmodium falciparum. Protein Expr Purif (2005) 1.00
Plasmodium falciparum: glycosylation status of Plasmodium falciparum circumsporozoite protein expressed in the baculovirus system. Exp Parasitol (2002) 0.86
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery. Science (2011) 3.07
Detection of four Plasmodium species by genus- and species-specific loop-mediated isothermal amplification for clinical diagnosis. J Clin Microbiol (2007) 3.00
Central role of the spleen in malaria parasite clearance. J Infect Dis (2002) 2.80
Malaria in the Greater Mekong Subregion: heterogeneity and complexity. Acta Trop (2011) 2.70
Comparison of PCR and microscopy for the detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in Thailand. Malar J (2006) 2.68
Comparison of field and expert laboratory microscopy for active surveillance for asymptomatic Plasmodium falciparum and Plasmodium vivax in western Thailand. Am J Trop Med Hyg (2002) 2.66
A cell-free protein synthesis system for high-throughput proteomics. Proc Natl Acad Sci U S A (2002) 2.55
Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat Genet (2010) 2.48
A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology (2012) 2.46
Spatio-temporal distribution of Plasmodium falciparum and p. Vivax malaria in Thailand. Am J Trop Med Hyg (2005) 2.41
Establishment of a human hepatocyte line that supports in vitro development of the exo-erythrocytic stages of the malaria parasites Plasmodium falciparum and P. vivax. Am J Trop Med Hyg (2006) 2.39
The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission. Am J Trop Med Hyg (2004) 2.32
Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob Agents Chemother (2003) 2.26
Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine (2005) 2.21
Hemoglobin E: a balanced polymorphism protective against high parasitemias and thus severe P falciparum malaria. Blood (2002) 2.19
Comparative evaluation of selected diagnostic assays for the detection of IgG and IgM antibody to Orientia tsutsugamushi in Thailand. Am J Trop Med Hyg (2002) 2.18
Infectivity of asymptomatic Plasmodium-infected human populations to Anopheles dirus mosquitoes in western Thailand. J Med Entomol (2004) 2.15
Effect of Ginkgo biloba on visual field and contrast sensitivity in Chinese patients with normal tension glaucoma: a randomized, crossover clinical trial. Invest Ophthalmol Vis Sci (2014) 2.12
Recrudescence in artesunate-treated patients with falciparum malaria is dependent on parasite burden not on parasite factors. Am J Trop Med Hyg (2003) 2.10
Genetic diversity and multiple infections of Plasmodium vivax malaria in Western Thailand. Am J Trop Med Hyg (2003) 1.98
Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med (2007) 1.95
Human protein factory for converting the transcriptome into an in vitro-expressed proteome,. Nat Methods (2008) 1.88
SURFIN is a polymorphic antigen expressed on Plasmodium falciparum merozoites and infected erythrocytes. J Exp Med (2005) 1.83
Identification of the Plasmodium vivax mdr-like gene (pvmdr1) and analysis of single-nucleotide polymorphisms among isolates from different areas of endemicity. J Infect Dis (2004) 1.83
Enhanced Recovery After Surgery (ERAS) program attenuates stress and accelerates recovery in patients after radical resection for colorectal cancer: a prospective randomized controlled trial. World J Surg (2012) 1.75
Multimodal e-mental health treatment for depression: a feasibility trial. J Med Internet Res (2010) 1.72
Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int J Parasitol (2007) 1.70
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development. J Immunol (2013) 1.68
Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity. Proc Natl Acad Sci U S A (2004) 1.66
Evidence for the transmission of Plasmodium vivax in the Republic of the Congo, West Central Africa. J Infect Dis (2009) 1.65
The deformability of red blood cells parasitized by Plasmodium falciparum and P. vivax. J Infect Dis (2004) 1.65
Epigenetic silencing of Plasmodium falciparum genes linked to erythrocyte invasion. PLoS Pathog (2007) 1.63
Perceived barriers to psychological treatments and their relationship to depression. J Clin Psychol (2010) 1.58
Cell-free expression systems for eukaryotic protein production. Curr Opin Biotechnol (2006) 1.58
A bilayer cell-free protein synthesis system for high-throughput screening of gene products. FEBS Lett (2002) 1.56
Deep knot structure for construction of active site and cofactor binding site of tRNA modification enzyme. Structure (2004) 1.53
Rhoptry neck protein RON2 forms a complex with microneme protein AMA1 in Plasmodium falciparum merozoites. Parasitol Int (2008) 1.52
Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitol Int (2006) 1.51
High prevalence of liver and intestinal fluke infections among residents of Savannakhet Province in Laos. Korean J Parasitol (2007) 1.51
Cultivation of Plasmodium vivax. Trends Parasitol (2008) 1.50
High prevalence of Haplorchis taichui, Phaneropsolus molenkampi, and other helminth infections among people in Khammouane province, Lao PDR. Korean J Parasitol (2009) 1.49
Plasmodium cynomolgi genome sequences provide insight into Plasmodium vivax and the monkey malaria clade. Nat Genet (2012) 1.49
Adaptation of a visualized loop-mediated isothermal amplification technique for field detection of Plasmodium vivax infection. Parasit Vectors (2011) 1.48
Natural human humoral response to salivary gland proteins of Anopheles mosquitoes in Thailand. Acta Trop (2006) 1.47
Practical cell-free protein synthesis system using purified wheat embryos. Nat Protoc (2010) 1.47
Concurrent infection with Heligmosomoides polygyrus modulates murine host response against Plasmodium berghei ANKA infection. Am J Trop Med Hyg (2008) 1.45
Plasmodium ookinete-secreted proteins secreted through a common micronemal pathway are targets of blocking malaria transmission. J Biol Chem (2004) 1.44
Transmission-blocking activities of quinine, primaquine, and artesunate. Antimicrob Agents Chemother (2006) 1.43
In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am J Trop Med Hyg (2004) 1.43
Anopheles kleini, Anopheles pullus, and Anopheles sinensis: potential vectors of Plasmodium vivax in the Republic of Korea. J Med Entomol (2007) 1.43
Field evaluation of the ICT Malaria Pf/Pv immunochromatographic test for the detection of asymptomatic malaria in a Plasmodium falciparum/vivax endemic area in Thailand. Am J Trop Med Hyg (2002) 1.40
Novel fluorescence labeling and high-throughput assay technologies for in vitro analysis of protein interactions. Genome Res (2002) 1.39
Gene structure and expression of a Plasmodium falciparum 220-kDa protein homologous to the Plasmodium vivax reticulocyte binding proteins. Mol Biochem Parasitol (2002) 1.38
A gene capable of blocking apoptosis can substitute for the herpes simplex virus type 1 latency-associated transcript gene and restore wild-type reactivation levels. J Virol (2002) 1.37
An engineered Escherichia coli tyrosyl-tRNA synthetase for site-specific incorporation of an unnatural amino acid into proteins in eukaryotic translation and its application in a wheat germ cell-free system. Proc Natl Acad Sci U S A (2002) 1.35
Evolutionary relationships of conserved cysteine-rich motifs in adhesive molecules of malaria parasites. Mol Biol Evol (2002) 1.33
Prevalence of Heterophyes nocens and Pygydiopsis summa infections among residents of the western and southern coastal islands of the Republic of Korea. Am J Trop Med Hyg (2004) 1.31
Highly stable and efficient mRNA templates for mRNA-protein fusions and C-terminally labeled proteins. Nucleic Acids Res (2003) 1.31
Circulating red cell-derived microparticles in human malaria. J Infect Dis (2011) 1.30
Roles of conserved amino acid sequence motifs in the SpoU (TrmH) RNA methyltransferase family. J Biol Chem (2005) 1.30
A novel herpes simplex virus type 1 transcript (AL-RNA) antisense to the 5' end of the latency-associated transcript produces a protein in infected rabbits. J Virol (2002) 1.30
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer. Malar J (2007) 1.29
Laboratory passage and characterization of an isolate of Toxoplasma gondii from an ocular patient in Korea. Korean J Parasitol (2003) 1.29
An outbreak of gnathostomiasis among Korean emigrants in Myanmar. Am J Trop Med Hyg (2003) 1.28
Apical expression of three RhopH1/Clag proteins as components of the Plasmodium falciparum RhopH complex. Mol Biochem Parasitol (2005) 1.26
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites. Infect Immun (2006) 1.25
Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J Immunol (2008) 1.23
Two types of Plasmodium ovale defined by SSU rRNA have distinct sequences for ookinete surface proteins. Mol Biochem Parasitol (2002) 1.23
An evolutionarily conserved Rit GTPase-p38 MAPK signaling pathway mediates oxidative stress resistance. Mol Biol Cell (2011) 1.22
Plasmodium vivax adherence to placental glycosaminoglycans. PLoS One (2012) 1.22
Novel protein fold discovered in the PabI family of restriction enzymes. Nucleic Acids Res (2007) 1.22
Interest in behavioral and psychological treatments delivered face-to-face, by telephone, and by internet. Ann Behav Med (2010) 1.21
Challenges and prospects for malaria elimination in the Greater Mekong Subregion. Acta Trop (2011) 1.21
Regulation of caspase 8- and caspase 9-induced apoptosis by the herpes simplex virus type 1 latency-associated transcript. J Neurovirol (2002) 1.20
Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays. J Proteome Res (2010) 1.18
Arabidopsis HY5 protein functions as a DNA-binding tag for purification and functional immobilization of proteins on agarose/DNA microplate. FEBS Lett (2007) 1.18